Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection

Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection

ABSTRACT This position statement of the Department of Hypertension of the Brazilian Society of Nephrology (SBN) addresses the controversy surrounding the use or suspension/replacement of the renin-angiotensin-aldosterone system blockers (particularly inhibitors of the angiotensin-converting enzyme or angiotensin II AT1 receptor blockers) prophylactically in individuals using these drugs, due to the possibility of allegedly worsening the prognosis of hypertensive patients infected with SARS-CoV-2. The SBN Hypertension Department recommends individualizing treatment and maintaining these medications until better scientific evidence is available.

Saved in:
Bibliographic Details
Main Author: Rodrigues,Cibele Isaac Saad
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Nefrologia 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002020000500047
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0101-28002020000500047
record_format ojs
spelling oai:scielo:S0101-280020200005000472020-12-04Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infectionRodrigues,Cibele Isaac Saad Coronavirus infections Hypertension Renin-Angiotensin System ABSTRACT This position statement of the Department of Hypertension of the Brazilian Society of Nephrology (SBN) addresses the controversy surrounding the use or suspension/replacement of the renin-angiotensin-aldosterone system blockers (particularly inhibitors of the angiotensin-converting enzyme or angiotensin II AT1 receptor blockers) prophylactically in individuals using these drugs, due to the possibility of allegedly worsening the prognosis of hypertensive patients infected with SARS-CoV-2. The SBN Hypertension Department recommends individualizing treatment and maintaining these medications until better scientific evidence is available.info:eu-repo/semantics/openAccessSociedade Brasileira de NefrologiaBrazilian Journal of Nephrology v.42 n.2 suppl.1 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002020000500047en10.1590/2175-8239-jbn-2020-s112
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Rodrigues,Cibele Isaac Saad
spellingShingle Rodrigues,Cibele Isaac Saad
Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
author_facet Rodrigues,Cibele Isaac Saad
author_sort Rodrigues,Cibele Isaac Saad
title Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_short Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_full Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_fullStr Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_full_unstemmed Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_sort position paper of the department of hypertension of the brazilian society of nephrology: use of renin-angiotensin system blockers during the course of covid-19 infection
description ABSTRACT This position statement of the Department of Hypertension of the Brazilian Society of Nephrology (SBN) addresses the controversy surrounding the use or suspension/replacement of the renin-angiotensin-aldosterone system blockers (particularly inhibitors of the angiotensin-converting enzyme or angiotensin II AT1 receptor blockers) prophylactically in individuals using these drugs, due to the possibility of allegedly worsening the prognosis of hypertensive patients infected with SARS-CoV-2. The SBN Hypertension Department recommends individualizing treatment and maintaining these medications until better scientific evidence is available.
publisher Sociedade Brasileira de Nefrologia
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002020000500047
work_keys_str_mv AT rodriguescibeleisaacsaad positionpaperofthedepartmentofhypertensionofthebraziliansocietyofnephrologyuseofreninangiotensinsystemblockersduringthecourseofcovid19infection
_version_ 1756392704512622592

Similar Items